Nkarta price target raised by $12 at H.C. Wainwright, » 06:13 NKTX
This biotech had a surge Jan 6 or so on no news that I can find. $12 PR raise is significant when the stock iself is $9!
Description
Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cell...